Systems and methods for nerve conduction block
Disclosed herein are systems and methods for nerve conduction block. The systems and methods can utilize at least one rechargeable electrode. The methods can include delivering a first direct current with a first polarity to an electrode proximate nervous tissue sufficient to at least partially block conduction in the nervous tissue.
1. A system for nerve block of a patient utilizing a capacitive rechargeable electrode, comprising:
a current generator;
at least one implantable electrode comprising titanium nitride, the at least one electrode configured to be in electrical communication with the current generator;
a sensor configured to determine a state of stored charge of the at least one implantable electrode; and
a controller configured to:
generate, by way of signaling to the current generator, a first current with a first polarity proximal to the at least one electrode sufficient to at least partially block conduction in a nerve, wherein an amount of stored charge in the at least one electrode decreases and generates current in an ionic component proximate the at least one electrode when the electrode is implanted within the patient;
generate, by way of signaling to the current generator, a second current with a second polarity proximal to the at least one electrode sufficient to increase the amount of stored charge in the at least one electrode;
receive data from the sensor;
determine if an amount of water is being electrolyzed; and
in response to determining that the amount of water is being electrolyzed, discontinuing at least one of the first current or the second current.
2. The system of claim 1 , wherein the decrease and increase in amount of stored charge on the at least one electrode are not equal.
3. The system of claim 1 , wherein the at least one electrode is housed in an insulated enclosure.
4. The system of claim 1 , wherein the titanium nitride comprises porous or fractal titanium nitride.
5. The system of claim 1 , wherein titanium nitride electrode is configured to deliver at least about 25,000 μC of charge into excitable tissue without damaging the excitable tissue.
6. The system of claim 1 , wherein the system is devoid of any mechanically moving parts.
7. The system of claim 1 , wherein titanium nitride electrode is configured to deliver at least about 5,000 μC of charge into excitable tissue without damaging the excitable tissue.
8. A system for nerve block of a patient utilizing a capacitive rechargeable electrode, comprising:
a current generator;
at least one implantable electrode comprising a high charge density material configured to be spaced apart from a nerve interface by an ionic component, the at least one implantable electrode configured to be in electrical communication with the current generator; and
a controller configured to signal the current generator to:
generate a first current with a first polarity proximal to the at least one implantable electrode sufficient to at least partially block conduction in a nerve, wherein an amount of stored charge in the at least one electrode decreases and generates current in an ionic component proximate the at least one electrode when the electrode is implanted within the patient; and
generate a second current with a second polarity proximal to the at least one implantable electrode sufficient to increase the amount of stored charge of the at least one implantable electrode;
wherein the first current comprises a smooth trapezoidal waveform that ramps up to a target anodic magnitude and ramps down to a target cathodic magnitude such that transitions between ramp regions and plateaus of the smooth trapezoidal waveform comprise a smoothing function.
9. The system of claim 8 , further comprising a sensor configured to determine the state of charge of the at least one implantable electrode, wherein the controller is further configured to receive data from the sensor and discontinue at least one of the first current or the second current when an amount of water is being electrolyzed.
10. The system of claim 8 , wherein the decrease and increase in amount of stored charge on the at least one electrode are not equal.
11. The system of claim 8 , wherein the at least one implantable electrode is configured to deliver at least about 5,000 μC of charge into excitable tissue without damaging the excitable tissue.
12. The system of claim 8 , wherein the at least one implantable electrode is configured to deliver at least about 25,000 μC of charge into excitable tissue without damaging the excitable tissue.
13. The system of claim 8 , wherein the system is devoid of any mechanically moving parts.
14. The system of claim 8 , wherein the at least one implantable electrode is at least partially surrounded by an electrolyte solution.
15. The system of claim 8 , wherein the high charge density material comprises titanium nitride.
16. The system of claim 8 , wherein the controller is configured to maintain the nerve in a hypersuppressed state at least partially preventing conduction of the nerve for at least about 10 minutes after cessation of delivering of the first current.
17. The system of claim 9 , wherein the smoothing function comprises a cubic hermite spline.
18. The system of claim 9 , wherein the smoothing function comprises at least first derivative continuity.
19. The system of claim 8 , wherein the ramp regions comprise leading ramp regions that approach plateaus and trailing ramp regions that trail plateaus, the leading ramp regions comprising a ramp rate that is lower than a ramp rate of the trailing ramp regions.